Improved detection of Pneumocystis jirovecii infection in a tertiary care reference hospital in India

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Pulmonology

Background:

• Pneumocystis pneumonia (PcP) is a serious opportunistic infection, particularly in immunocompromised individuals.
• Accurate and timely diagnosis of PcP is crucial for effective treatment and patient outcomes.
• Microscopic techniques have limitations in sensitivity for PcP diagnosis.

Purpose of the Study:

• To compare the diagnostic performance of PCR assay versus microscopy for Pneumocystis jirovecii detection.
• To evaluate the utility of PCR in immunocompromised patients with suspected PcP.

Main Methods:

• Prospective study of 143 clinical samples from 115 patients (HIV-infected and HIV-uninfected immunocompromised) with lung infiltrates.
• Samples included bronchoalveolar lavage (BAL), tracheal aspirate (TA), nasopharyngeal aspirate (NPA), sputum, and gastric aspirate (GA).
• Comparison of PCR assay with Gomori methenamine silver (GMS) staining microscopy.

Main Results:

• P. jirovecii positivity rate was 12.17% by PCR versus 3.4% by microscopy.
• PCR showed 100% sensitivity and 99% specificity, while microscopy had 30.7% sensitivity and 100% specificity.
• No P. jirovecii was detected in 21 control individuals with other respiratory diseases.

Conclusions:

• PCR assay is significantly more sensitive and specific than microscopy for diagnosing PcP.
• PCR is a valuable tool for confirming and improving PcP diagnosis in high-risk patient populations.
• The findings support the routine use of PCR for PcP detection in clinical settings.